Clinical trials

  • Allogeneic peripheral blood-derived haematopoietic stem cells, TCR alpha/beta+ CD19+ depleted for Neuroblastoma | Relapsed or refractory high-risk neuroblastoma
  • anakinra for Systemic juvenile idiopathic arthritis (sJIA) | Still's disease
  • PF-07999415
  • Ambroxol for Parkinson's disease
  • Beta-lactam antibacterials, penicillins for Acute lower respiratory tract infection | Acute rhinosinusitis
  • DEPEMOKIMAB for Eosinophilic asthma
  • RIVAROXABAN for Short bowel syndrome
  • SEMAGLUTIDE for Type 2 diabetes
  • 2'-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE TARGETING UBE3A ANTISENSE TRANSCRIPT RNA for Angelman syndrome
  • ENLICITIDE CHLORIDE for Heterozygous familial hypercholesterolemia
  • LIRAGLUTIDE for Obesity
  • LEVOTHYROXINE SODIUM for Acute unilateral vestibulopathy (AUVP) | Vestibular function disorder